ATE486079T1 - Azatricyclische verbindungen und deren verwendung - Google Patents

Azatricyclische verbindungen und deren verwendung

Info

Publication number
ATE486079T1
ATE486079T1 AT07786995T AT07786995T ATE486079T1 AT E486079 T1 ATE486079 T1 AT E486079T1 AT 07786995 T AT07786995 T AT 07786995T AT 07786995 T AT07786995 T AT 07786995T AT E486079 T1 ATE486079 T1 AT E486079T1
Authority
AT
Austria
Prior art keywords
compounds
azatricyclic
azatricyclic compounds
antibacterials
containing compounds
Prior art date
Application number
AT07786995T
Other languages
English (en)
Inventor
Gerald Brooks
Timothy James Miles
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE486079T1 publication Critical patent/ATE486079T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT07786995T 2006-07-03 2007-07-03 Azatricyclische verbindungen und deren verwendung ATE486079T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0613208.8A GB0613208D0 (en) 2006-07-03 2006-07-03 Compounds
PCT/EP2007/056664 WO2008003690A1 (en) 2006-07-03 2007-07-03 Azatricyclic compounds and their use

Publications (1)

Publication Number Publication Date
ATE486079T1 true ATE486079T1 (de) 2010-11-15

Family

ID=36888558

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07786995T ATE486079T1 (de) 2006-07-03 2007-07-03 Azatricyclische verbindungen und deren verwendung

Country Status (7)

Country Link
US (1) US20100004230A1 (de)
EP (1) EP2041145B1 (de)
JP (1) JP2009541456A (de)
AT (1) ATE486079T1 (de)
DE (1) DE602007010147D1 (de)
GB (1) GB0613208D0 (de)
WO (1) WO2008003690A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006335042A1 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Compounds
ES2344523T3 (es) 2005-12-22 2010-08-30 Glaxo Group Limited Compuestos heterociclicos, su preparacion y su uso como agentes antibacterianos.
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
TW200831517A (en) * 2006-12-15 2008-08-01 Astrazeneca Ab Chemical compounds
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
JP5389013B2 (ja) * 2007-04-20 2014-01-15 グラクソ グループ リミテッド 抗菌剤としての三環式含窒素化合物
US8349828B2 (en) 2008-02-20 2013-01-08 Actelion Pharmaceuticals Ltd. Azatricyclic antibiotic compounds
BRPI0916571A2 (pt) 2008-08-04 2015-11-10 Actelion Pharmaceuticals Ltd composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
PT2344495E (pt) * 2008-10-07 2015-04-01 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
EP2352734A1 (de) 2008-10-17 2011-08-10 Glaxo Group Limited Als antibakterielle mittel verwendete tricyclische stickstoffverbindungen
NZ593891A (en) 2008-12-12 2013-05-31 Actelion Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
CN101870653B (zh) * 2009-04-23 2013-07-10 上海合全药业有限公司 一种2-甲基-3-氟-6-硝基苯甲酸的合成方法
TWI487709B (zh) 2009-12-18 2015-06-11 Basilea Pharmaceutica Ag 三環抗生素
ES2596369T3 (es) 2011-06-17 2017-01-09 Basilea Pharmaceutica Ag Antibióticos N-heterotricíclicos
AR087875A1 (es) 2011-09-16 2014-04-23 Actelion Pharmaceuticals Ltd Proceso para la elaboracion de derivados de piridazina como intermediarios de sintesis de antibioticos
CN103958525A (zh) 2011-11-30 2014-07-30 埃科特莱茵药品有限公司 3,7-二取代八氢-2H-吡啶并[4,3-e][1,3]噁嗪-2-酮抗生素
EP3639824A1 (de) 2014-08-22 2020-04-22 GlaxoSmithKline Intellectual Property Development Limited Tricyclische stickstoffhaltige verbindungen zur behandlung einer infektion mit neisseria gonorrhoea
SMT202200201T1 (it) 2016-02-12 2022-07-21 Cytokinetics Inc Derivati di tetraidroisochinolina

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
FR2798656B1 (fr) 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
IL154107A0 (en) 2000-07-26 2003-07-31 Smithkline Beecham Plc Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
GB0031088D0 (en) 2000-12-20 2001-01-31 Smithkline Beecham Plc Medicaments
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0118238D0 (en) 2001-07-26 2001-09-19 Smithkline Beecham Plc Medicaments
WO2003064421A1 (en) 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine derivatives
AU2003239302A1 (en) 2002-01-29 2003-09-02 Glaxo Group Limited Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
TW200406413A (en) 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
GB0217294D0 (en) 2002-07-25 2002-09-04 Glaxo Group Ltd Medicaments
TW200427688A (en) 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
DE10316081A1 (de) 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
FR2872164B1 (fr) 2004-06-29 2006-11-17 Aventis Pharma Sa Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
JP2008509222A (ja) 2004-08-09 2008-03-27 グラクソ グループ リミテッド 抗菌剤
DE102004041163A1 (de) 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
CA2581057A1 (en) 2004-10-05 2006-04-13 Actelion Pharmaceuticals Ltd New piperidine antibiotics
EP1900732A4 (de) 2005-06-24 2009-11-18 Toyama Chemical Co Ltd Neue nitrogenierte heterocyclische verbindung und salz davon
AU2006335042A1 (en) * 2005-10-21 2007-07-19 Glaxo Group Limited Compounds
ES2344523T3 (es) * 2005-12-22 2010-08-30 Glaxo Group Limited Compuestos heterociclicos, su preparacion y su uso como agentes antibacterianos.
ATE481406T1 (de) * 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) * 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
EP2041145A1 (de) 2009-04-01
US20100004230A1 (en) 2010-01-07
JP2009541456A (ja) 2009-11-26
GB0613208D0 (en) 2006-08-09
EP2041145B1 (de) 2010-10-27
WO2008003690A1 (en) 2008-01-10
DE602007010147D1 (de) 2010-12-09

Similar Documents

Publication Publication Date Title
ATE486079T1 (de) Azatricyclische verbindungen und deren verwendung
CR9930A (es) Compuestos
TW200801001A (en) Compounds
CR20150586A (es) Compuestos triciclicos que contienen nitrogeno como agentes antibactercianos
SG173374A1 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
MY153915A (en) Organic compounds
EP2488601A4 (de) Elektrochrome verbindung, elektrochrome zusammensetzung und anzeigeelement
CY1116261T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
GB2460579A (en) Silylethynylated heteroacenes and electronic devices made therewith
JO2778B1 (en) Certain Compounds, Compositions and Methods
TW200704751A (en) Novel materials for organic electroluminescent devices
DE502006000603D1 (de) Planetenträger
TW200636046A (en) Novel materials for organic electroluminescent devices
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
ATE473229T1 (de) Tricyclische verbindungen und deren verwendung als mglur1-antagonisten
MX2007008137A (es) Triazoloftalazinas como inhibidores de pde2.
DK2254873T3 (da) Benzodiazepinforbindelse og farmaceutisk sammensætning.
TW200715634A (en) Stable organic devices
DE502006004472D1 (de) Organische elektrolumineszenzvorrichtungen
GB0508314D0 (en) Organic compounds
TW200700358A (en) Organic compounds
TW200738608A (en) Organic compounds
ATE539082T1 (de) Oxazinylisoflavonoidverbindungen, medikamente und anwendungen
EA200971067A1 (ru) Триазолиламинопиримидиновые соединения
NO20091386L (no) Fenyloksyanilinderivater

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties